Clinical trial Recruiting at 4 sites Interventional Women only

Community-informed maternal sepsis safety bundle in NYC hospitals (Aim 1)

Official title: EnCoRe MoMS Aim 1: Develop and Implement a Community-informed Institutional Obstetric Sepsis Bundle

Run by Columbia University · NCT06145724 · Data updated 2026-11-12

This project will try a community-informed maternal sepsis safety bundle in four New York City hospitals to reduce sepsis during labor, birth, and the postpartum period for birthing people.

Quick facts

Study typeInterventional
SexWomen only
Enrollment33183 (estimated)
SponsorColumbia University
Academic / other
Locations4 sites (New York, New York and 3 other locations)
StatusRecruiting
StartedJune 1, 2025
Main results expectedAugust 31, 2026
Study endsSeptember 20, 2026
Registry record updatedJanuary 21, 2026
Trial IDNCT06145724 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Birthing people who had delivery hospitalizations or associated postpartum readmissions at one of the four participating hospitals between 2020 and 2025 are the focus of this work.

Probably not a fit

People who deliver at hospitals outside the four participating sites or whose care occurred outside the 2020–2025 window would not be included and therefore would not receive any direct benefit from this implementation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

EnCoRe MoMS partners community leaders, clinicians, and researchers to design and implement a maternal sepsis safety bundle across four New York City hospitals. Aim 1a established community engagement structures and a CoLAB to create a bundle that combines readiness, recognition, response, reporting, respectful care, provider training, and screening for unmet needs. Aim 1b uses a pre–post implementation design with electronic health record review of delivery hospitalizations and related postpartum readmissions between 2020 and 2025 to compare outcomes before and after bundle rollout. Participants are followed through the delivery hospitalization to discharge and any pertinent readmissions to measure sepsis events and related morbidity.

Why it matters

Potential benefit: If successful, the bundle could reduce maternal sepsis cases, complications, and deaths by improving early recognition and standardizing timely responses.

How similar studies have gone: Professional groups (ACOG, SMFM) recommend sepsis safety bundles but direct evidence of their effectiveness is limited, and this community-informed, multi-center pre–post evaluation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Birthing Person (EMR evaluation):

-Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025

Exclusion Criteria:

Birthing Person (EMR evaluation)

-Delivery hospitalizations (and associated postpartum readmissions)to a hospital other than the 4 hospital sites or outside of 2020-2025 timeframe

Where it's running

  • Columbia Unviersity Irving Medical Center
    New York, New York, United States
    Recruiting
  • NewYork-Presbyterian Allen Hospital
    New York, New York, United States
    Recruiting
  • NYC Health+Hospitals/Harlem
    New York, New York, United States
    Recruiting
  • NYC Health + Hospitals/Lincoln
    The Bronx, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.